Similar articles

• [Protection of the mouse after oral vaccination by means of a orally administered killed pathogen strain of Salmonella typhimurium].

  Ivanoff B, Creach O, Fontanges R. Ivanoff B, et al. C R Seances Soc Biol Fil. 1974;168(4-5):541-5. C R Seances Soc Biol Fil. 1974. PMID: 4281693 French. No abstract available.
• Experimental study of vaccines against Salmonella typhimurium infection.

  Severtsova MK, Stanislavsky ES, El'-Bashir AM, Zaidner IG. Severtsova MK, et al. J Hyg Epidemiol Microbiol Immunol. 1979;23(3):318-25. J Hyg Epidemiol Microbiol Immunol. 1979. PMID: 393775
• [Protective action on mice of acellular extracts from Salmonella typhimurium].

  Golebiowski TE, Tinelli RL. Golebiowski TE, et al. C R Acad Hebd Seances Acad Sci D. 1978 Jun;286(22):1633-5. C R Acad Hebd Seances Acad Sci D. 1978. PMID: 97021 French.
• [Experimental protective immunization of mice against S. typhimurium infection by Salmonella R mutants].

  Schlecht S. Schlecht S. Zentralbl Bakteriol Orig A. 1974;227(1-4):250-6. Zentralbl Bakteriol Orig A. 1974. PMID: 4154594 German. No abstract available.
• Hybrid hepatitis B virus core antigen as a vaccine carrier moiety. II. Expression in avirulent Salmonella spp. for mucosal immunization.

  Schödel F, Kelly S, Tinge S, Hopkins S, Peterson D, Milich D, Curtiss R 3rd. Schödel F, et al. Adv Exp Med Biol. 1996;397:15-21. Adv Exp Med Biol. 1996. PMID: 8718577 Review.